http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8101384-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34652dde6c58de8b3d2a18a9125d6d48
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
filingDate 1979-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1980-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8101384-A1
titleOfInvention PROCEDURE FOR THE PREPARATION OF CYTOTOXIC PRODUCTS
abstract PROCEDURE FOR OBTAINING CYTOTOXIC SUBSTANCES. IT CONSISTS OF COPULATING THE A CHAIN OF RICIN THROUGH A DISULFIDE BRIDGE WITH A PROTEIN STRUCTURE SUCH AS AN ANTIBODY, IMMUNOGLOBULIN, OR IMMUNOGLOBULIN FRAGMENTS. AS A STARTING POINT, THE GROSS EXTRACT OF GRAINS OF <<RICINES COMMUNIS>> IS PURIFIED BY CHROMATOGRAPHY ON A SEPHAROSE 4 B COLUMN. THE PURE SOLUTION OBTAINED IS CHROMATOGRAPHY IN A LOW IONIC STRENGTH BUFFER TO WHICH A REDUCING AGENT SUCH AS AS 2-MERCAPTOETHANOL. FINALLY, A P1-SH COMPOUND IS REACTED WITH ANOTHER P2-S-S-X, SO THAT WHEN P1 IS THE RADICAL OF THE A CHAIN OF RICIN, P2 IS AN IMMUNOGLOBULIN, OR AN IMMUNOGLOBULIN FRAGMENT, AND WHEN P1 IS AN IMMUNOGLOBULIN OR ONE FRAGMENT, P2 IS A RADICAL OF THE A CHAIN OF RICIN, WITH X BEING AN ACTIVATING RADICAL. CANCER TREATMENT.
priorityDate 1978-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02879

Total number of triples: 34.